NCT07608822

BIO|STREAM.CSP CLS

RecruitingOBSERVATIONAL

Trial Details

Start: 2026-05-29Est. Completion: 2028-05-29

Enrollment target: 150 participants

Locations

Masarykova nemocnice v Usti nad Labem, Ústí nad Labem, Czechia
Semmelweis University, Budapest, Hungary
University of Szeged, Szeged, Hungary
Ospedale Di Summa - Perrino, Brindisi, Italy
Niguarda hospital, Milan, Italy
A.O.U. Maggiore della Carita di Novara, Novara, Italy
Ospedale di Piove di Sacco, Piove di Sacco, Italy
Fondazione Policlinico Universitario "Agostino Gemelli" Università Cattolica del Sacro Cuore, Roma, Italy
SS Annunziata Taranto, Taranto, Italy
Unidade local de Saúde de Coimbra, EPE - Centro Hospitalar Universitario de Coimbra, Coimbra, Portugal
Hospital Universitario 12 de Octubre, Madrid, Spain
Hospital Universitario La Fe, Valencia, Spain

Contact

Martina Del MaestroCLS-CSP-STREAM@biotronik.com

Other microbiome trials you might be interested in

Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck CancerPhase 1Recruiting

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Recurrent Cutaneous Squamous Cell Carcinoma of the Head and NeckRecurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Oral Cavity Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell CarcinomaRecurrent Paranasal Sinus Squamous Cell CarcinomaRecurrent Salivary Gland CarcinomaStage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8Stage III Hypopharyngeal Carcinoma AJCC v8

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.